The traps to model before choosing multi-month
Three traps recur. Titration: if a patient on a multi-month semaglutide supply moves up a dose, the remaining lower-dose product may be unusable — custom-compounded preparations have a defined beyond-use date and cannot be returned, so the discount you booked is offset by waste. Drop-off: cash-pay patients churn, and a multi-month supply paid ahead is a loss if the patient stops. Cash flow: multi-month buys tie up working capital and inventory risk that a monthly cadence does not. Against those, multi-month does offer real upside — fewer orders, lower shipping cost per dose (South Lake Pharmacy ships from a single Florida location, so batching reduces per-dose freight), and simpler refill operations — so the decision is a genuine trade-off.
To evaluate it with South Lake Compounding, ask for per-vial cost on both month and multi-month options for your top SKUs as itemized lines in the clinic agreement, then compute per-dose cost under a realistic completion rate rather than 100%. If you expect a meaningful share of patients to titrate or drop off, discount the multi-month savings accordingly. Only compare the adjusted per-dose numbers — that is where the trap shows up or disappears.